What Are Optimal P2Y12 Inhibitor and Schedule of Administration in Patients With Acute Coronary Syndrome?
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
What Are Optimal P2Y12 Inhibitor and Schedule of Administration in Patients With Acute Coronary Syndrome?
Authors
Keywords
-
Journal
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
Volume -, Issue -, Pages 107424841988292
Publisher
SAGE Publications
Online
2019-10-24
DOI
10.1177/1074248419882923
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Platelet Inhibition with Cangrelor and Crushed Ticagrelor in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Results of the CANTIC Study
- (2019) Francesco Franchi et al. CIRCULATION
- Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial
- (2019) Derek J Hausenloy et al. LANCET
- Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes
- (2019) Stefanie Schüpke et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized controlled trial of remote ischaemic conditioning in ST-elevation myocardial infarction as adjuvant to primary angioplasty (RIC-STEMI)
- (2018) António Gaspar et al. BASIC RESEARCH IN CARDIOLOGY
- Myocardial Infarct Size Reduction Provided by Local and Remote Ischaemic Preconditioning: References Values from the Hatter Cardiovascular Institute
- (2018) Xavier Rossello et al. CARDIOVASCULAR DRUGS AND THERAPY
- No Benefit of Ticagrelor Pretreatment Compared With Treatment During Percutaneous Coronary Intervention in Patients With ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
- (2018) Sasha Koul et al. Circulation-Cardiovascular Interventions
- Cangrelor in Ticagrelor-Loaded STEMI Patients Undergoing Primary Percutaneous Coronary Intervention
- (2018) Dimitrios Alexopoulos et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Do We Need Potent Intravenous Antiplatelet Inhibition at the Time of Reperfusion During ST-Segment Elevation Myocardial Infarction
- (2018) Joseph Allencherril et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention
- (2017) Muthiah Vaduganathan et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cangrelor-Mediated Cardioprotection Requires Platelets and Sphingosine Phosphorylation
- (2016) Michael V. Cohen et al. CARDIOVASCULAR DRUGS AND THERAPY
- Ticagrelor and Rosuvastatin Have Additive Cardioprotective Effects via Adenosine
- (2016) Yochai Birnbaum et al. CARDIOVASCULAR DRUGS AND THERAPY
- Protective Effects of Ticagrelor on Myocardial Injury After InfarctionClinical Perspective
- (2016) Gemma Vilahur et al. CIRCULATION
- Pharmacodynamic Assessment of Platelet Reactivity After a Loading Dose of Prasugrel or Clopidogrel in Patients With ST-Segment Elevation Myocardial Infarction
- (2016) Shinya Ichikawa et al. CIRCULATION JOURNAL
- Transition strategies from cangrelor to oral platelet P2Y12 receptor antagonists
- (2016) David J. Schneider CORONARY ARTERY DISEASE
- Cangrelor in combination with ticagrelor provides consistent and potent P2Y12-inhibition during and after primary percutaneous coronary intervention in real-world patients with ST-segment-elevation myocardial infarction
- (2016) Moman A. Mohammad et al. PLATELETS
- Ticagrelor Protects the Heart Against Reperfusion Injury and Improves Remodeling After Myocardial InfarctionSignificance
- (2015) Yumei Ye et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Cyclosporine A reduces microvascular obstruction and preserves left ventricular function deterioration following myocardial ischemia and reperfusion
- (2015) Jaroslaw Zalewski et al. BASIC RESEARCH IN CARDIOLOGY
- Cardioprotective Properties of the Platelet P2Y12 Receptor Inhibitor, Cangrelor: Protective in Diabetics and Reliant Upon the Presence of Blood
- (2015) R. M. Bell et al. CARDIOVASCULAR DRUGS AND THERAPY
- Cardioprotection by combined intrahospital remote ischaemic perconditioning and postconditioning in ST-elevation myocardial infarction: the randomized LIPSIA CONDITIONING trial
- (2015) Ingo Eitel et al. EUROPEAN HEART JOURNAL
- Remote Ischemic Conditioning Reduces Myocardial Infarct Size and Edema in Patients With ST-Segment Elevation Myocardial Infarction
- (2015) Steven K. White et al. JACC-Cardiovascular Interventions
- Cyclosporine before PCI in Patients with Acute Myocardial Infarction
- (2015) Thien-Tri Cung et al. NEW ENGLAND JOURNAL OF MEDICINE
- Signalling pathways and mechanisms of protection in pre- and postconditioning: historical perspective and lessons for the future
- (2014) Michael V Cohen et al. BRITISH JOURNAL OF PHARMACOLOGY
- Prehospital Ticagrelor in ST-Segment Elevation Myocardial Infarction
- (2014) Gilles Montalescot et al. NEW ENGLAND JOURNAL OF MEDICINE
- Two Classes of Anti-Platelet Drugs Reduce Anatomical Infarct Size in Monkey Hearts
- (2013) Xi-Ming Yang et al. CARDIOVASCULAR DRUGS AND THERAPY
- Triple Therapy Greatly Increases Myocardial Salvage During Ischemia/Reperfusion in the in situ Rat Heart
- (2013) Xi-Ming Yang et al. CARDIOVASCULAR DRUGS AND THERAPY
- Remote Ischemic Post-Conditioning of the Lower Limb During Primary Percutaneous Coronary Intervention Safely Reduces Enzymatic Infarct Size in Anterior Myocardial Infarction
- (2013) Gabriele Crimi et al. JACC-Cardiovascular Interventions
- Comparison of Prasugrel and Ticagrelor Loading Doses in ST-Segment Elevation Myocardial Infarction Patients
- (2013) Guido Parodi et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Consensus and Update on the Definition of On-Treatment Platelet Reactivity to Adenosine Diphosphate Associated With Ischemia and Bleeding
- (2013) Udaya S. Tantry et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study
- (2013) Gregg W Stone et al. LANCET
- Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events
- (2013) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pretreatment with Prasugrel in Non–ST-Segment Elevation Acute Coronary Syndromes
- (2013) Gilles Montalescot et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular risk among patients on clopidogrel anti-platelet therapy after placement of drug-eluting stents is modified by genetic variants in both the CYP2C19 and ABCB1 genes
- (2013) Stacey Knight et al. THROMBOSIS AND HAEMOSTASIS
- A high loading dose of clopidogrel reduces myocardial infarct size in patients undergoing primary percutaneous coronary intervention: A magnetic resonance imaging study
- (2012) Young Bin Song et al. AMERICAN HEART JOURNAL
- Cardioprotection by clopidogrel in acute ST-elevated myocardial infarction patients: a retrospective analysis
- (2012) François Roubille et al. BASIC RESEARCH IN CARDIOLOGY
- Platelet P2Y12 Blockers Confer Direct Postconditioning-Like Protection in Reperfused Rabbit Hearts
- (2012) Xi-Ming Yang et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Prognostic Value of a High On-Clopidogrel Treatment Platelet Reactivity in Bivalirudin Versus Abciximab Treated Non–ST-Segment Elevation Myocardial Infarction Patients
- (2012) Dirk Sibbing et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Platelet Reactivity and Cardiovascular Outcomes After Percutaneous Coronary Intervention
- (2011) Matthew J. Price et al. CIRCULATION
- Prasugrel Overcomes High On-Clopidogrel Platelet Reactivity Post-Stenting More Effectively Than High-Dose (150-mg) Clopidogrel
- (2011) Dimitrios Alexopoulos et al. JACC-Cardiovascular Interventions
- Selective Blockade of P2Y12 Receptors by Prasugrel Inhibits Myocardial Infarction Induced by Thrombotic Coronary Artery Occlusion in Rats
- (2011) Atsuhiro Sugidachi et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- A comparison between upfront high-dose tirofiban versus provisional use in the real-world of non-selected STEMI patients undergoing primary PCI
- (2011) A.A.C.M. Heestermans et al. Netherlands Heart Journal
- Platelet Aggregation and Its Association With Stent Thrombosis and Bleeding in Clopidogrel-Treated Patients
- (2010) Dirk Sibbing et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial
- (2010) Shamir R Mehta et al. LANCET
- Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial
- (2010) Hans Erik Bøtker et al. LANCET
- Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease
- (2009) Paul A. Gurbel et al. CIRCULATION
- Pharmacokinetics and Pharmacodynamics of a Bolus and Infusion of Cangrelor: A Direct, Parenteral P2Y12 Receptor Antagonist
- (2009) Wendell S. Akers et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Role of Clopidogrel Loading Dose in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Angioplasty
- (2009) George Dangas et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial
- (2009) Gilles Montalescot et al. LANCET
- Early versus Delayed, Provisional Eptifibatide in Acute Coronary Syndromes
- (2009) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- (2009) Lars Wallentin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Limitation of myocardial infarct size in the clinical setting: current status and challenges in translating animal experiments into clinical therapy
- (2008) Tetsuji Miura et al. BASIC RESEARCH IN CARDIOLOGY
- Cytochrome P450 2C19 681G>A Polymorphism and High On-Clopidogrel Platelet Reactivity Associated With Adverse 1-Year Clinical Outcome of Elective Percutaneous Coronary Intervention With Drug-Eluting or Bare-Metal Stents
- (2008) Dietmar Trenk et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Genetic Determinants of Response to Clopidogrel and Cardiovascular Events
- (2008) Tabassome Simon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Transitioning patients from cangrelor to clopidogrel: Pharmacodynamic evidence of a competitive effect
- (2007) Steven R. Steinhubl et al. THROMBOSIS RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now